Cécile Denis
97
Documents
Publications
MICAL1 links actin dynamics to shear-dependent adhesive and thrombotic function of plateletsCongrès Français d’Hémostase, May 2023, Saint-Malo, France
Poster de conférence
hal-04455404v1
|
|
Effect of allele-selective silencing of von Willebrand factor in mice on experimental bleeding and thrombosis modelsCongress of the International Society on Thrombosis and Haemostasis, Jun 2023, Montreal, Canada. Res. Pract. Thromb. Haemost., 7 (Suppl. 2), pp.Abstract PB 1431, 2023
Poster de conférence
hal-04501158v1
|
|
Le récepteur PAR4 initie la voie SERCA3/NAADP qui potentialise l'activation des plaquettes en réponse à la thrombine.Congrès Francais d'Hémostase, May 2023, Saint malo, France
Poster de conférence
hal-04455436v1
|
|
MAGT1 DEFICIENCY CAUSES A PROMINENT PLATELETS DYSFUNCTION THROUGH IMPAIRMENT OF MEMBRANE GLYCOPROTEINS N-GLYCOSYLATION20th Biennial Meeting of the European Society for Immunodeficiencies (ESID), Oct 2022, Gothenburg, Sweden. Abstract 801
Poster de conférence
hal-04455514v1
|
|
Resistance to Fibrinolysis in Critically Ill Patients with COVID-19 Can Be Overcome by N-acetylcysteine in vitroHybrid Congress of the International Society on Thrombosis and Haemostasis, Jul 2021, Philadelphia (Pennsylvania), United States. Res. Pract. Thromb. Haemost, 5 (Suppl. 1), pp.Abstract LPB0104, 2021
Poster de conférence
hal-04501103v1
|
|
NAADP/SERCA3-Dependent Ca2+ Stores Pathway Specifically Controls Early Autocrine ADP Secretion Potentiating Platelet ActivationVirtual Congress of the International Society on Thrombosis and Haemostasis, Jul 2020, Milan (Virtual), Italy. Res. Pract. Thromb. Haemost, 4 (Suppl. 1), pp.Abstract PB1745, 2020
Poster de conférence
hal-04501065v1
|
|
Prothrombotic gain-of-functin variants of von Willebrand factor.Virtual Congress of the International Society on Thrombosis and Haemostasis, Jul 2020, Milan (Virtual), Italy. Res. Pract. Thromb. Haemost, 4 (Suppl. 1), pp.Abstract PB1584, 2020
Poster de conférence
hal-04501054v1
|
|
Standardization of a Flow Cytometry Platelet Sialylation Assay, and reference Values forBeta-Galactose Exposure in Healthy SubjectsISTH, 2020, Jul 2020, Milan (Italie), Italy. PB0441
Poster de conférence
hal-04454870v1
|
|
Von Willebrand Factor Induces Vascular Smooth Muscle Cell Proliferation And Migration Through Low Density Lipoprotein-Related Receptor Protein 4 And αvβ3 IntegrinAmerican Heart Association's Vascular Discovery: From Genes to Medicine 2020 Scientific Sessions, May 2020, Virtual meeting (Live and on-demand), France. Arteriosclerosis, Thrombosis, and Vascular Biology, 40 (Suppl1), pp.Abstract 304, 2020
Poster de conférence
hal-04499901v1
|
|
Transplacental delivery of maternal factor VIII for induction of immune tolerance to therapeutic factor VIIIVirtual Congress of the International Society on Thrombosis and Haemostasis, Jul 2020, Milan (Virtual), Italy. Res. Pract. Thromb. Haemost, 4 (Suppl. 1), pp.Abstract PB0177, 2020
Poster de conférence
hal-04501045v1
|
|
The VWF-GPIb interaction mediates thrombo-inflammation in experimental stroke via recruitment of monocytes, neutrophils and T-cells to the brainXXVIIth Congress of the International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia. Res. Pract. Thromb. Haemost., 3 (Suppl. 1), pp.Abstract PB1002, 2019
Poster de conférence
hal-04499886v1
|
|
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand diseaseGRC, Cell biology of megakaryocytes and platelets, 2019, Mar 2019, Galveston - Texas, United States
Poster de conférence
hal-04455289v1
|
|
Phosphoinositide 3-kinase (PI3K) triggers PI3K activation at low levels of GPVI stimulation and controls platelet arrest on von Willebrand factor ar arterial shear.XXVIIth Congress of the International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia. Res. Pract. Thromb. Haemost, 3 (Suppl. 1), pp.Abstract PB463, 2019
Poster de conférence
hal-04499868v1
|
|
Development of single domain antibodies targeting protease nexin-1 as a strategy for hemophilia treatmentXXVIIth Congress of the International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia. Res. Pract. Thromb. Haemost, 3 (Suppl. 1), pp.Abstract PB0316, 2019
Poster de conférence
hal-04499858v1
|
|
Modulation of the platelet count by Romiplostim and inhibitors of LIM kinase in genetically-engineered von Willebrand disease type 2B mice: in vivo evaluation of haemostatic efficiency.ECTH, 2018, Oct 2018, Marseille, France
Poster de conférence
hal-04455308v1
|
L'angiopoïétine-2 se lie à de multiples sites interactifs au sein du facteur von Willebrand44ème congrès de la Société Française d'Hématologie, Société Française d'Hématologie, Mar 2024, Paris, France. pp.P327, Abstract 18-03
Communication dans un congrès
inserm-04541054v1
|
|
Llama-derived single-domain antibodies blocking tissue factor pathway inhibitor and increasing thrombin generation in FVIII- and FX-deficient plasmaEuropean Congress on Thrombosis and Haemostasis, Sep 2023, Valence (Espagne), Spain
Communication dans un congrès
hal-04501177v1
|
|
MICAL1, un nouvel acteur moléculaire impliqué dans la stabilisation du thrombusCongrès Société Française d’Hématologie 2023, Mar 2023, Paris, France
Communication dans un congrès
hal-04455383v1
|
|
A single-domain antibody enhancing protein S activity reduces vaso-occlusion in two murine models of sickle cell diseaseEuropean Congress on Thrombosis and Haemostasis, Sep 2023, Valence (Espagne), Spain
Communication dans un congrès
hal-04501174v1
|
|
Allele-selective inhibition of mutant von Willebrand factor with small interfering RNAs to ameliorate a von Willebrand disease type 2B phenotype in vivo in miceCongress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jun 2023, Montreal (Canada), Canada. pp.100553. Abstract OC 08.5
Communication dans un congrès
hal-04501151v1
|
|
Effects of platelet-inspired haemostatic nanoparticles on bleeding in von Willebrand disease murine modelsISTH 2022 Congress, International Society of Thrombosis and Hemostasis, 2022, Londres, United Kingdom
Communication dans un congrès
hal-04455066v1
|
|
MICAL1, un nouvel acteur des forces contractiles dans le thrombusClub Français de Plaquettes et des Mégacaryocytes, May 2022, Bordeaux, France
Communication dans un congrès
hal-04455372v1
|
|
Antithrombotic Potential of a Single-domain Antibody Enhancing the Anticoagulant Activity of Protein SHybrid Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2021, Philadelphia (Pennsylvania), United States. pp.Abstract OC 60.2
Communication dans un congrès
hal-04501112v1
|
|
Transplacental Delivery of Maternal FVIII for Induction of FVIII-specific Immune ToleranceHybrid Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2021, Philadelphia (Pennsylvania), United States. pp.Abstract OC 14.1
Communication dans un congrès
hal-04501088v1
|
|
Caractérisation d’une nanobody qui potentialize l’activité cofacteur de la protéine C active de la protéine S40ème congrès de la Société Française d’Hématologie, Société Française d’Hématologie, Sep 2020, Paris, France. pp.Page 39, Abstract 04-01
Communication dans un congrès
hal-04501074v1
|
|
p.(Pro2145Thrfs*5) et p.(Cys2216Phefs*9), deux Nouvelles mutations identifiées dans le domaine D4 du facteur von Willebrand chez des patientes d’origine afro-caribéenne40ème congrès de la Société Française d’Hématologie, Société Française d’Hématologie, Sep 2020, Paris, France. p 50, Abstract 05-07
Communication dans un congrès
hal-04501081v1
|
|
L'ADP sécrétée par la voie de signalisation calcique plaquettaire NAADP/SERCA3 active spécifiquement le récepteur purinergique P2Y12 et pas P2Y18ème rencontre Club français des plaquettes et des mégacayocytes, Nov 2020, plateforme zoom, France
Communication dans un congrès
hal-04455261v1
|
|
Diagnostic moléculaire de la maladie de von Willebrand de type 1C avec trouble de la clairance et mutation de la région propeptide39th Congress of the Société Française d’Hématologie, Société Française d’Hématologie, Mar 2019, Paris, France. pp.142
Communication dans un congrès
hal-04498426v1
|
|
A inducible mouse model of Factor X deficiency to test novel FX therapeuticsXXVIIth Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia. pp.Abstract OC 28.4
Communication dans un congrès
hal-04499851v1
|
|
Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia AXXVIIth Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia. pp.Abstract OC 75.3
Communication dans un congrès
hal-04498448v1
|
|
Développement d’un modèle de souris avec un déficit inductible en facteur X39th Congress of the Société Française d’Hématologie, Société Française d’Hématologie, Mar 2019, Paris, France. pp.Abstract 12-29
Communication dans un congrès
hal-04498403v1
|
|
La rupture de l'interaction entre la filamine A et le complexe aIIbb3 conduit à l'activation de la voie RhoA entraînant une macrothrombocytopénie39th Congress of the Société Française d’Hématologie, Société Française d’Hématologie, Mar 2019, Paris, France. pp.142
Communication dans un congrès
hal-04498415v1
|
|
Von Willebrand factor induces human vascular smooth muscle cells proliferation through low density lipoprotein-related receptor 4 and alphavbeta3 integrinXXVIIth Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia
Communication dans un congrès
hal-04498513v1
|
|
La Protéase Nexine-1, un inhibiteur physiologique de la thrombine, cible potentielle dans le traitement de l’hémophilie.38th Congress of the Société Française d’Hématologie, Société Française d’Hématologie, Mar 2018, PARIS, France. p 133, Abstract 12-59
Communication dans un congrès
hal-04457483v1
|
|
The potential use of nanobodies delivered via AAV vectors in the treatment of hemophilia21st Annual Meeting of the American Society of Gene and Cell Therapy, American Society of Gene and Cell Therapy, May 2018, CHICAGO, United States
Communication dans un congrès
hal-04457494v1
|
|
Maladie de Willebrande type 2B et thrombopénies : Impact de la désialylation des plaquettes.38th Congress of the Société Française d’Hématologie, Société Française d’Hématologie, Mar 2018, Paris, France. pp.Page 143, Abstract 12-88
Communication dans un congrès
hal-04457466v1
|
|
Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia A2nd European Congress on Thrombosis and Haemostasis, Oct 2018, Marseille, France
Communication dans un congrès
hal-04457505v1
|
Thrombin-mediated cleavage of membrane endoglin: Implications in endothelial dysfunction17th Annual Congress of the European Association for Haemophilia and Allied Disorders 2024, Haemophilia, 30 (S1), pp.34-188, 2024, ⟨10.1111/hae.14919⟩
Proceedings/Recueil des communications
hal-04460082v1
|
|
Thrombin-mediated activation of factor VIII is insufficient to produce all necessary cofactor activity in vivoCongress of the International Society of Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis, 3, pp.1-891, 2019, ⟨10.1002/rth2.12229⟩
Proceedings/Recueil des communications
hal-04461945v1
|
Évaluation des communautés thérapeutiques en France. Quelle mise en oeuvre, quels résultats ? Etude prospective sur deux ans dans quatre communautés thérapeutiques[Rapport de recherche] Observatoire français des drogues et toxicomanies (OFDT); Mission interministérielle de lutte contre la drogue et la toxicomanie (MILDT); Direction générale de la santé (DGS). 2011
Rapport
halshs-00594027v1
|